Catalyst Crew Technologies Corp. (OTC: CCTC), a digital health and artificial intelligence technology company, announced that its Chief Executive Officer, Dr. Kevin Rodan Levy, will attend HLTH Europe 2026, an international healthcare conference taking place in Amsterdam from June 15-18. The company views this as a strategic opportunity to engage with industry leaders, observe emerging trends, and seek potential partnerships that could accelerate its development of telehealth and AI-driven healthcare platforms for emerging markets.
Dr. Levy's attendance aligns with the company's broader strategy to expand its digital health ecosystem, which includes telehealth infrastructure, remote patient monitoring, healthcare data analytics, and integrated care platforms. According to the press release, the company believes that participating in major international conferences provides valuable insights into industry developments and helps strengthen professional networks. HLTH Europe is expected to convene healthcare executives, innovators, investors, and technology leaders from global markets, focusing on healthcare transformation and digital infrastructure.
“As we continue advancing our digital health and artificial intelligence initiatives, attending major international healthcare events provides valuable opportunities to observe emerging industry trends, engage with healthcare innovators, and further strengthen our long-term strategic positioning,” said Dr. Levy.
Catalyst Crew Technologies is currently focused on building scalable digital health solutions for Latin America and other emerging markets. The company is transitioning into AI-enabled healthcare, pursuing opportunities across telehealth, remote monitoring, and data analytics to improve access and care coordination. The company's strategic initiatives include technology development, partnerships, and targeted acquisitions to build an integrated platform addressing growing demand for modernized healthcare delivery.
For more information about Catalyst Crew Technologies, visit https://catalystcrewai.com or review its filings with the U.S. Securities and Exchange Commission at www.sec.gov.
This announcement underscores the company's commitment to advancing its digital health strategy through active participation in global healthcare innovation events. The company cautions that forward-looking statements involve risks and uncertainties, and actual results may differ materially. As a development-stage enterprise, Catalyst Crew Technologies has not yet generated revenues from its new business direction, and there is no assurance of successful implementation of its business plan.
